Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In patients with type 2 diabetes, treatment with semaglutide 1 mg resulted in reductions in glucose in terms of absolute change from baseline and relative reduction compared to placebo of 29 mg/dL (22%) for fasting glucose, 74 mg/dL (36%) for 2 hour postprandial glucose, and 30 mg/dL (22%) for mean 24 hour glucose concentration (see Figure 1)
We provide the data to help you have a more productive conversation with your medical professional
In patients with type 2 diabetes, dual agonists can have powerful benefits for glucose control and weight reduction
Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng Y, et al
Both are exactly the same medication, dosages and results
US$ 25.94
US$ 20.88
US$ 24.28
US$ 25.50
